Prevalence of the Novel COVD-19 in Nangarhar Province Corona Center Hospital during June 2020 to August 2021


Shukrullah Sahak
Abdul Nasir Jabarkhil
Salahuddin Rahime
Habibullah Mulavizada
Kamran Zafarzai


Background: In 2019, a novel coronavirus appeared, quickly circling the world from its Chinese source. The illness brought on by this virus is known as coronavirus disease 2019 (COVID-19), and the virus was given the designation SARS-CoV-2 by the Centers for Disease Control and Prevention. On March 11, 2020, the World Health Organization proclaimed COVID-19 to be a pandemic. During 2020, the virus spread to Afghanistan and infected thousands of individuals. This study's aim is to describe the incidence of COVID-19 in the Nangarhar Corona Center Hospital in Afghanistan between June 2020 and August 2021. Thus, quick administration of the necessary therapy can stop future complications. Additionally, the management of upcoming pandemic virus illnesses will benefit from this study's findings.
Materials and Methods: A descriptive retrospective investigation using interview approach and an accidental sampling technique was used to collect data for this study from the inpatient medical records of patients who were identified as having SARS-CoV-2 infection following admission to the Corona Center Hospital in Nangarhar province, Afghanistan, between June 2020 and August 2021. Additionally, information on the laboratory tests was taken from the hospital file. In addition, 140 patients were questioned about their ischemic heart disease, diabetes, hypertension, and other COVID-19 risk factors. Additionally, 100 patients were given a questionnaire about the socioeconomic effects of COVID-19 on their daily lives and behavior.
Findings: In this study, patients who met the inclusion criteria provided 11000 samples. 3380 female patients and 7620 male patients in all have been reported. There were 9267 negative cases and 1733 positive cases out of them. 1133 (10.1%) of the positive instances were found in male patients, whereas 600 (5.5%) were found in female patients. The 140 patients who were examined for COVID-19 risk factors identified four, including hypertension, diabetes, chronic liver disorders, and ischemic heart disease. Additionally, 75% of participants believed that COVID-19 would be controlled in Afghanistan, compared to 70% who believed that COVID-19 would be managed globally.
Conclusion: The findings of this study indicated that the majority of COVID-19 patients were of productive age. Additionally, our study found that there was a negative overall influence of COVID-19 on Afghan population social life. Immediate action is required on the part of the general public in the shape of focused mass psychological support initiatives in order to improve the mental health of those impacted by the COVID-19 problems.


Coronavirus, Disease, Health, Nangarhar Province, Patients, Prevalence factors


How to Cite
Sahak, S., Jabarkhil, A. N., Rahime, S., Mulavizada , H. ., & Zafarzai, K. (2023). Prevalence of the Novel COVD-19 in Nangarhar Province Corona Center Hospital during June 2020 to August 2021. NUIJB, 2(03), 72–79. Retrieved from


  1. Babarinsa, I. A., Okunoye, G. O., & Odukoya, O. (2021). Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy–An overview. European Journal of Obstetrics & Gynecology and Reproductive Biology, 263, 171-175.
  2. Balkhi, F., Nasir, A., Zehra, A., & Riaz, R. (2020). Psychological and behavioral response to the coronavirus (COVID-19) pandemic. Cureus, 12(5).
  3. Dergaa, I., Abdelrahman, H., Varma, A., Yousfi, N., Souissi, A., Ghram, A., ... & Farzian, S. (2021). COVID-19 vaccination, herd immunity and the transition toward normalcy: challenges with the upcoming sports events. Annals of Applied Sport Science, 9(3), 1-12.
  4. Ganesan, B., Al-Jumaily, A., Fong, K. N., Prasad, P., Meena, S. K., & Tong, R. K. Y. (2021). Impact of coronavirus disease 2019 (COVID-19) outbreak quarantine, isolation, and lockdown policies on mental health and suicide. Frontiers in psychiatry, 12, 565190.
  5. Ganesan, B., Al-Jumaily, A., Fong, K. N., Prasad, P., Meena, S. K., & Tong, R. K. Y. (2021). Impact of coronavirus disease 2019 (COVID-19) outbreak quarantine, isolation, and lockdown policies on mental health and suicide. Frontiers in psychiatry, 12, 565190.
  6. Hassan, S. A., Sheikh, F. N., Jamal, S., Ezeh, J. K., & Akhtar, A. (2020). Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus, 12(3).
  7. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
  8. Jee, Y. (2020). WHO international health regulations emergency committee for the COVID-19 outbreak. Epidemiology and health, 42.
  9. Jordan, J. J., Yoeli, E., & Rand, D. G. (2021). Don’t get it or don’t spread it: Comparing self-interested versus prosocial motivations for COVID-19 prevention behaviors. Scientific reports, 11(1), 20222.
  10. Khudadad, U., Safi, N., Aftab, W., Ali, A., & Siddiqi, S. (2021). The COVID-19 pandemic: an opportunity to strengthen health systems in Afghanistan. Eastern Mediterranean Health Journal, 27(3), 220-223.
  11. Li, L., Qin, L., Xu, Z., Yin, Y., Wang, X., Kong, B., ... & Xia, J. (2020). Using artificial intelligence to detect COVID-19 and community-acquired pneumonia based on pulmonary CT: evaluation of the diagnostic accuracy. Radiology, 296(2), 65-71.
  12. Liu, D. X., Liang, J. Q., & Fung, T. S. (2021). Human coronavirus-229E,-OC43,-NL63, and-HKU1 (Coronaviridae). Encyclopedia of virology, 428.
  13. Munster, V. J., Koopmans, M., Van Doremalen, N., Van Riel, D., & de Wit, E. (2020). A novel coronavirus emerging in China-key questions for impact assessment. New England Journal of Medicine, 382(8), 692-694.
  14. Nadeem, M., Ilyas, U., Umer, A., Raffae, A., Ajmal, S. B., Ali, Z., & Umar, H. M. T. (2022). Impact of Lockdown due to Covid-19 Pandemic on Construction Industry of Pakistan. Pakistan Journal of Engineering and Technology, 5(1), 42-48.
  15. Semenzato, L., Botton, J., Drouin, J., Cuenot, F., Dray-Spira, R., Weill, A., & Zureik, M. (2021). Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. The Lancet Regional Health–Europe, 8.
  16. Sen, M., Honavar, S. G., Bansal, R., Sengupta, S., Rao, R., Kim, U., ... & Sowjanya, Y. (2021). Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India–Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian journal of ophthalmology, 69(7), 1670-1692.
  17. Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., ... & Zheng, C. (2020). Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet infectious diseases, 20(4), 425-434.
  18. Tadic, M., Cuspidi, C., Grassi, G., & Mancia, G. (2020). COVID‐19 and arterial hypertension: hypothesis or evidence?. The Journal of Clinical Hypertension, 22(7), 1120-1126.
  19. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. jama, 323(11), 1061-1069.
  20. Zhang, J. J., Dong, X., Cao, Y. Y., Yuan, Y. D., Yang, Y. B., Yan, Y. Q., ... & Gao, Y. D. (2020). Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 75(7), 1730-1741.
  21. Zhou, Y., Chi, J., Lv, W., & Wang, Y. (2021). Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19). Diabetes/metabolism research and reviews, 37(2), e3377.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)